Pharmaceuticals

  1. Industry Sectors
  2. Pharmaceuticals
Find Healthcare, Medical & Pharmaceutical ads at NewsNow Classifieds/Jobs
Roche torches a mountain of biobucks, sweeping out a roster of R&D programs in the latest pipeline cleanup ENDPOINTS11:50
Prescription painkillers reclassified amid addiction concerns Pharmafile11:09
UK launch for first eosinophilic oesophagitis drug PharmaTimes11:06
Roche signs $1 billion deal with cell therapy firm SQZ biotech Pharmafile11:49
Roche posts modest third-quarter sales beat as new drugs offset hit from copies Reuters.co.uk07:19
Beset by copies, Roche gets sales boost from China Reuters.co.uk09:11
FDA approves Pfizer's Talzenna for breast cancer alongside tool to identify eligible patients Pharmafile11:19
Samsung Bioepis’ Humira biosimilar launches in EU pharmaphorum11:16
Ocrevus surge keeps Roche smiling in Q3 PMLiVE11:12
China’s Pharmaceutical Firms Feel First Impact from Trump's Trade War Caixin Global08:20
Does the patent system need fixing? CapX10:59
Pregabalin and gabapentin reclassified as class C drugs, UK Government announces Hospital Healthcare Europe10:31
Choose date and time: ×
In the last 10 minutes
Allergan plans to file for U.S. approval of new migraine drug by Q1 of 2019 MarketWatch12:51
In the last 15 minutes
China delivers $1.3bn fine to vaccine producer over data falsification in-PharmaTechnologist.com12:43
In the last half-hour
FDA lists 205 molecular targets for pediatric cancer research ENDPOINTS12:40
China delivers $1.3bn fine to vaccine producer over falsifying data in-PharmaTechnologist.com12:32
GMP deficiency at contractor site lands Acacia Pharma CRL in-PharmaTechnologist.com12:32
EMA places Zhejiang Huahai under ‘increased supervision’ over quality issues in-PharmaTechnologist.com12:32
Johnson & Johnson Edges Past Profit Estimates, Lifts Outlook European Supermarket Magazine12:32
Samsung and Bioepis launch third Humira biosimilar in Europe Pharmafile12:29
In the last hour
Exclusive: Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug Reuters12:25
Market Risers: Lookers Plc, AstraZeneca plc, Shire PLC, Halma plc, Hargreaves Lansdown PLC &… DirectorsTalk Interviews12:14
2018's Biotech IPO Bonanza: View From the After Market Forbes12:12
Clinical Trial Liability Revisited, Briefly Drug & Device Law12:09
Orchard Therapeutics plans to go public to raise $172m Biopharma Reporter12:07
In the last 2 hours
London’s health and care system hampering STP progress, finds report PharmaTimes11:56
Earnings Reaction History: Abbott Laboratories, 54.5% Follow-Through Indicator, 2.3% Sensitive Nasdaq11:55
Samsung BioLogics may face legal action for alleged accounting breach Pharmaceutical Technology11:54
Kurdistan passes restrictions on shady pharmaceutical deals Kurdistan2411:52
Roche torches a mountain of biobucks, sweeping out a roster of R&D programs in the latest pipeline cleanup ENDPOINTS11:50
Roche signs $1 billion deal with cell therapy firm SQZ biotech Pharmafile11:49
Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows Pharmafile11:39
Iran, Uruguay to expand parliamentary ties Mehr News Agency11:38
SQZ Biotech signs up to $1bn immuno-oncology deal with Roche Pharmaceutical Technology11:24
FDA approves Pfizer's Talzenna for breast cancer alongside tool to identify eligible patients Pharmafile11:19
Pfizer’s Talzenna PARP breast cancer drug approved in US pharmaphorum11:16
Samsung Bioepis’ Humira biosimilar launches in EU pharmaphorum11:16
Cadila gets USFDA approval to market Clobetasol Propionate Crea India Info Line11:14
Ocrevus surge keeps Roche smiling in Q3 PMLiVE11:12
Trump officials ratchet up drug pricing fight The Hill11:11
Prescription painkillers reclassified amid addiction concerns Pharmafile11:09
AZ/MSD’s Lynparza assigned Orphan status in US PharmaTimes11:06
Another Humira biosimilar hits EU shores PharmaTimes11:06
UK launch for first eosinophilic oesophagitis drug PharmaTimes11:06
Pfizer’s Talzenna cleared for breast cancer PharmaTimes11:06
Avantium and BASF in dispute over Synvina bioplastics JV Plastics News Europe10:59
Does the patent system need fixing? CapX10:59
In the last 4 hours
SPI Pharma launches Mannogem XL mannitol Manufacturing Chemist10:52
Geographic distribution of antibiotics after market introduction European Pharmaceutical Review10:50
Zydus Cadila gets USFDA nod to market skin treatment cream MoneyControl.com10:47
Pfizer bags an FDA OK for PARP player talazoparib -- now the hard part begins ENDPOINTS10:40
ACG group rebrands under single new identity Manufacturing Chemist10:32
We can now customize cancer cures, tumor by tumor MIT Technology Review10:32
Pregabalin and gabapentin reclassified as class C drugs, UK Government announces Hospital Healthcare Europe10:31
Decline in novel testing technologies for antimicrobial resistance Pharmaceutical Field10:23
ACG group rebrands under single new ACG identity Manufacturing Chemist10:12
First Humira biosimilars reach EU market PMLiVE10:11
The message older voters will send in the midterm elections MarketWatch10:02
Johnson & Johnson Edges Past Profit Estimates And Lifts Outlook Checkout09:58
Roche reports sales growth as new drugs ease pressure from biosimilar competition Pharmaceutical Technology09:53
Restoring trust in medical research among African-Americans STAT09:51
Trump wants drug commercials to include prices. These five companies have the most at stake STAT09:49
DNA-based molecular computing will pave the way for programmable pills MIT Technology Review09:31
Beset by copies, Roche gets sales boost from China Reuters.co.uk09:11
FDA approves Myriad’s BRACAnalysis CDx as companion diagnostic for Pfizer’s Talzenna Compelo09:07
Samsung Bioepis launches Imraldi biosimilar in Europe Yonhap News Agency09:02
Cannabis is now legal in Canada, but pot companies expect a rocky start MarketWatch08:59
In the last 6 hours
Samsung launches third rival to AbbVie's Humira drug in EU Reuters.co.uk08:55
Roche 9-month Sales Rise; Backs FY18 Outlook RTT News08:45
Humira Copycats Launch In Europe As AbbVie Preps To Defend $6 Billion Investors Business Daily08:27
Can Regeneron Squeeze Another Use Out Of Blockbuster Hopeful Dupixent? Investors Business Daily08:27
China’s Pharmaceutical Firms Feel First Impact from Trump's Trade War Caixin Global08:20
4 shares with bright dividend outlooks? SSE PLC, AstraZeneca plc, Royal Mail PLC and BP plc Investomania08:10
Germany’s Merck to Centralize R&D Spending for Chemicals Business The Wall Street Journal08:03
Price controls, falling rupee push pharma industry to withdraw 11 drugs from market Sri Lanka Daily Mirror07:58
Roche posts modest third-quarter sales beat as new drugs offset hit from copies Reuters.co.uk07:19
Tie-Up Moves Kangstem's Novel Stem Cell Therapy Towards Globalization Scrip Pharma Intelligence07:18
Forget animal testing. These miniature, lab-grown human hearts are making drugs safer Wired UK07:17
Roche posts modest Q3 sales beat as new drugs offset hit from copies Reuters.co.uk07:13
In the last 8 hours
Piramal considers $1-billion pharma services business sale: Reports MoneyControl.com06:46
Roche posts modest third quarter sales beat as new drugs offset biosimilar hit Reuters.co.uk06:39
Roche posts modest Q3 sales beat as new drugs offset biosimilar hit Reuters.co.uk06:34
Roche 9-month Group Sales Rise 7%; Confirms FY18 Outlook - Quick Facts RTT News06:31
The Federal Reserve Is Not A Church – OpEd Eurasia Review06:21
Purdue Pharma, Eisai announce positive topline results from Phase 3 study of lemborexant News-Medical.Net06:07
FDA, DHS announce memorandum of agreement to address cybersecurity in medical devices News-Medical.Net06:07
Eton IPO: EM-100 Expects To Receive Marketing Approval In 2019 Seeking Alpha06:01
Researchers awarded grant to advance testing of experimental heroin vaccine News-Medical.Net05:57
Earlier today
Pharma industry withdraws 11 drugs from market: Importing not commercially viable Lanka Business Online03:32
Maharashtra government wants life sentence for those selling dodgy food, drugs DNA India01:05
Marijuana stocks to watch: Aurora Cannabis investments may be more valuable than its pot MarketWatch00:46
The New Kings of Pot? FXstreet00:38
Some supplements contain potentially harmful drugs Gulf Times00:23
Pfizer Expands In Breast Cancer With Talazoparib Approval Scrip Pharma Intelligence00:04
Clearasil and Johnson & Johnson acne ads banned in ASA cosmetics crackdown The Drum00:04
Neon Therapeutics Is An Emerging Player In Personalized Immunotherapy With Catalysts Ahead Seeking Alpha00:01
AcelRx Pharmaceuticals Gets A Thumbs Up From Advisory Committee Seeking Alpha00:01
Yesterday
Brainstorm Health: J&J CEO on Drug Prices, Polio-Like Condition, Pfizer Breast Cancer Drug Fortune23:57 16-Oct-18
J&J Pharma Growth Led By Oncology; Firm Tries To Assuage Zytiga Concerns Scrip Pharma Intelligence23:44 16-Oct-18
Moody's downgrades Akorn to B3; outlook changed to developing Moody's23:28 16-Oct-18
BMS, Compugen Pursue Multiple Checkpoint Inhibitions In Antibody Collaboration Scrip Pharma Intelligence23:14 16-Oct-18
Rule 36 Affirmances at the Federal Circuit – Week of October 8, 2018 IPWatchdog.com23:12 16-Oct-18
J&J says putting drug prices in ads may scare away patients Advertising Age23:06 16-Oct-18
Hundreds of Supplements Have Been Found to Contain Hidden Drugs—Even Viagra Health.com22:47 16-Oct-18
Pharmaceutical Industry withdraws 11 drugs Lakehouse Daily News22:44 16-Oct-18
Cost of blood pressure drug surges in U.S. after recall Reuters22:37 16-Oct-18
Warp Drive Bio bought by California company Boston Globe22:07 16-Oct-18
Martin Shkreli Is Still Talking The New Yorker21:59 16-Oct-18
Roche to deploy Iqvia’s tech suite across more than 100 markets Outsourcing-Pharma.com21:55 16-Oct-18
Cellular therapy CDMO Cognate to create center of excellence with Terumo Outsourcing-Pharma.com21:55 16-Oct-18
The last days of Theranos — the financials were as overhyped as the blood tests MarketWatch21:47 16-Oct-18
AstraZeneca, Merck Obtain Orphan Drug Designation for Lynparza for Pancreatic Cancer Drug Discovery & Development21:46 16-Oct-18
UnitedHealth, Johnson & Johnson and Morgan Stanley jump KSL.com, Utah21:43 16-Oct-18
Drug companies may be forced to reveal list prices in TV ads ABC News Channel 2021:42 16-Oct-18
Drugmakers Funnel Millions to Lawmakers Medpage Today21:23 16-Oct-18

About our Pharma news...

NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication. N.B. Relevance is automatically assessed so some headlines not qualifying as pharma news might appear - please feel free to contact us regarding any persistent issues. [Read more]

NewsNow Classifieds » Jobs » Top Searches

more
© Copyright 1997 - 2018 NewsNow Publishing Limited. All rights reserved.

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!
Site View
Publication filters

Headline Density

  • We may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, please read our Privacy Policy and Cookie Policy, which also explains how you can control cookies. By clicking "OK" or continuing to use this site, you agree to allow such ads to be shown and cookies to be set.
Sorry, no headlines or news topics were found. Please try different keywords.
Rest of site